DESPITE THE SIGNIFICANT ADVANCES in clinical care, sepsis and multiple organ failure (MOF) are still common causes of morbidity and mortality in the surgical intensive care unit (26) . Although the etiology of the development of MOF is poorly understood, it has been proposed that failure of the gut barrier may play a critical role in the initiation and development of this state. In this respect, the localized gut immune system is thought to be important in maintaining both gut function and integrity (9) . However, the physiological and pathological mechanism by which the mucosal immune system contributes to the initiation and development of the syndrome of MOF is poorly understood.
Apoptosis or programmed cell death is a tightly regulated cellular suicide program that plays a critical role in development and homeostasis in immune and central nervous systems of many organisms (29) . However, the induction of apoptosis in certain immune cells is recognized as a pathological process that can be regulated by various agents, a number of which are also stress mediators that are released during trauma and sepsis (12) . Previous studies from our laboratory (4) documented that lymphoid tissue such as thymus, bone marrow, and Peyer's patch shows evidence of increased apoptosis after the onset of sepsis. One possible mechanism that might contribute to the onset of MOF, in which intestinal mucosal immune function might be affected after sepsis, could be related to pathological changes in the mechanisms controlling apoptosis in the intestinal immune system. However, little is known about the localized intestinal immune response to sepsis and/or the pathophysiological responses that control it. Intestinal lamina propria (LP) lymphocytes, located in close proximity to the intestinal lumen and mucosal barrier, serve a major role in immune surveillance and are functionally distinct from peripheral blood T lymphocytes (37) . Although recent studies (4, 11, 17, 18, 20) demonstrated a correlation between increased apoptotic cell death in the intestinal mucosal immune cells (including LP lymphocytes) and septic challenge, little information is available concerning the mechanisms by which these apoptotic changes in the small intestinal LP B cell population are regulated.
In general, apoptosis of B lymphocytes is mediated through the B cell antigen receptor by antigens or through CD95/Fas receptor, a member of the tumor necrosis factor (TNF) receptor family (8, 24) . Although B cell receptor ligation results in deletion by apoptosis, this is dependent on the developmental stage of the B cell as well as on the nature of the antigen and signals derived from coreceptors (21) . Fas-mediated cell death is a component of activation-induced cell death and elimination of autoreactive T and B cells (8) . Boirivant et al. (7) demonstrated that the increased apoptosis of stimulated human LP T lymphocytes is mediated by the Fas/Fas ligand (FasL) pathway. Bacterial lipopolysaccharide (LPS) or endotoxin, a polyclonal B cell activator, has also been shown to induce increased apoptosis in B lymphocytes (36) . In a previous report, we (11) provided evidence of increased apoptosis in B lymphocytes in LP of C3H/HeN endotoxin-sensitive mice after the onset of polymicrobial sepsis. In addition, we (4) also demonstrated that the increase of Peyer's patch B lymphocyte apoptosis is Fas mediated and associated with activation of IgA release by these cells. To examine the potential mechanism(s) contributing to apoptosis, here we have investigated whether endotoxin and/or Fas/FasL pathway induces apoptosis in the LP B cell population and the effect of this on B cell function such as IgA release during sepsis. To the extent that these changes are linked to ability of the animal to survive septic challenge, we also examined the impact of deficiency of these mediators on the septic animal's mortality. Cecal ligation and puncture. Polymicrobial sepsis was induced in mice according to the method described by Baker et al. (5) and Ayala et al. (3) . Briefly, mice were lightly anesthetized with Metofane (methoxyflurane; Pitman-Moore, Mundelein, IL), shaved at the abdomen, and scrubbed with Betadine. A midline incision (1.5-2.0 cm) was made below the diaphragm to expose the cecum. The cecum was ligated and punctured twice with a 22-gauge needle and gently compressed to extrude a small amount of cecal contents through the punctured holes. The cecum was returned to the abdomen, and the incision was closed in layers with 6-0 Ethilon suture (Ethicon, Somerville, NJ). The animals then were resuscitated with 0.6 ml of lactated Ringer solution by subcutaneous injection. For the sham-operated controls, the animals were subjected to the same surgical procedure, i.e., laparotomy and cecal isolation, but the cecum was neither ligated nor punctured. For the survival study, mice were subjected to the cecal ligation and puncture (CLP) procedure and monitored for mortality over a 28-day period.
MATERIALS AND METHODS

Animals
Isolation and purification of LP mononuclear cells. LP mononuclear cells (LPMC) were isolated using the method described by Davies and Parrott (14) with some modifications. The animals were killed by Metofane overdose, and the small intestine was immediately removed and washed thoroughly with cold Hanks' balanced salt solution (HBSS, calcium and magnesium free; GIBCO, Grand Island, NY). The Peyer's patches, fat, and mesentery were dissected out, and the gut was slit open and cut into segments (0.5-1 cm). The gut segments were incubated for 90 min at 37°C in three changes of 30 ml of HBSS containing 1 mM dithiothreitol and 1 mM EDTA (Sigma Chemical, St. Louis, MO) with continuous shaking to remove epithelial cells. After two washes with HBSS, the segments were incubated for 1 h at 37°C in AIM-V serum-free medium containing 25 U/ml collagenase type II (Worthington Biochemical, Freehold, NJ) with continuous shaking. After incubation, the cell suspension was collected by passing through a stainless steel sieve and filtered by passing over a loosely packed nylon wool column at room temperature to remove mucus, tissue debris, and dead cells. The cells were washed twice with RPMI 1640 complete medium with 2% FCS. Isolated LPMC were further purified on a Percoll (Sigma Chemical) gradient (14) . The cell pellets were resuspended in 2 ml 100% Percoll (prepared by mixing 1 part of 10ϫ PBS with 9 parts of Percoll), which was overlaid with 6 ml of 40% Percoll (diluted from 100% Percoll with AIM-V medium) in a 15-ml conical tube and centrifuged at 600 g for 20 min. Cells collected from the interface of the 40% and 100% Percoll were washed twice and resuspended in AIM-V medium at 10 6 cells/ml. The viability of recovered cells was determined by trypan blue exclusion. Recovered cells were found to be Ͼ90% viable.
Cell staining and flow cytometric analysis. Two-color flow cytometric analysis was carried out to determine the percentage of phenotypic expression and apoptosis according to methods previously described by our laboratory (11) . In a typical staining protocol, LPMC (1 ϫ 10 6 cells) were suspended in 100 l of staining buffer (1% BSA and 0.01% sodium azide in PBS) containing 10 g/ml nonspecific mouse IgG known as Fc blocker and incubated on ice for 15 min. The cells were then stained with anti-Fas (clone Jo2, hamster IgG conjugated to FITC) and anti-B220 (clone RA3-6B2, rat IgG2a conjugated to Cychrome; Pharmingen, San Diego, CA). Control cells were stained with isotypic antibodies corresponding to each monoclonal antibody described above. The stained cells were fixed (1% paraformaldehyde in PBS) overnight at 4°C, washed with PBS, and resuspended in PBS for analysis. For the determination of apoptosis frequency, the fixed cells were subjected to terminal dUTP nick-end labeling (TUNEL)-FITC (Boehringer, Indianapolis, IN) staining. After incubation at 37°C for 1 h, the reaction was terminated and cells were resuspended in 0.5 ml PBS and stored in the dark at 4°C before analysis.
Two-color analysis was performed on FACSort flow cytometer (Becton-Dickinson, San Jose, CA). FITC and Cychrome were excited at 488 nm with the argon laser. FITC fluorescent emission was detected at 525 nm and Cychrome emission at 670 nm. The overlapping emission of FITC and Cychrome was corrected by electronic compensation, and no fewer than 10,000 cells were assessed in each sample. PCLysis version 1.0 software (Becton-Dickinson) was used to determine the percentage of cells expressing antigenic markers according to the fluorescence intensity of the nonspecific isotypic antibody controls. The percentage of apoptotic cells was determined based on the positive (DNase treated) and negative (DNase untreated) sham-operated animal cell controls.
IgA ELISpot assay. An ELISpot assay was used to determine the number of LPMC secreting IgA (16) . Purified LPMC were cultured (10 5 cells/well) on monoclonal anti-mouse IgA (5 g/ml; Pharmingen)-precoated (4°C, overnight) nitrocellulose filtration plates (Millipore, Bedford, MA). After washing and incubation (4°C, overnight) with a secondary biotinylated monoclonal anti-mouse IgA antibody (2.5 g/ml, Pharmingen), the plates were developed with avidin-peroxidase-H2O2-ACE (3-amino-9-ethylcarbazole in 0.1 mol/l sodium acetate buffer, pH 5.0). The number of spots present in the membrane was counted on a Mocha Image analysis system (Jandel Scientific, Corte Madera, CA).
Light microscopic examination. A 2-cm-long section of ileum was excised and immediately fixed in 10% buffered formaldehyde. Paraffin-embedded tissues were sectioned at 5 m thick for staining with hematoxylin and eosin. In an attempt to roughly quantify the extent of apoptotic change present in these samples, 10 random fields at ϫ600 magnification (between villi and muscular layer in which the LP are found) were screened in a blinded fashion for each sample from a total of 3 animal samples in every group of animals. Apoptosis was characterized by chromatin condensation, reduction in nuclear volume, increased cytoplasmic density, and nuclear pyknosis. The extent of apoptosis was then scored by using the morphological scale of Hotchkiss et al. (18) with minor modification, in which the arbitrary scales were given as follows: 0, Ͻ1% the cells in the field are apoptotic; 1, 1-5% of cells are apoptotic; 2. 5.1-10% of cells are apoptotic; 3, 0.1-15% of cells are apoptotic; and 4, Ͼ15.1% of cells are apoptotic.
Presentation of data and statistical analysis. Data are presented as means Ϯ SE for each group. Differences in percentile data (i.e., percentage of apoptosis positive and Fas positive) were considered to be significant if P Ͻ 0.05, as determined by the Mann-Whitney U-test. Differences in the extent of the apoptotic scale of the histology data were considered to be significant if P Ͻ 0.05, as analyzed by Student's t-test. The survival data were compared using Fisher's exact test and considered to be significant at P Ͻ 0.05.
RESULTS
Polymicrobial sepsis induces changes in LP B cell population from C3H/HeJ (endotoxin tolerant) but not C3H/HeJ-FasL gld mice (endotoxin tolerant/FasL deficient).
Phenotypes of isolated LPMC were characterized by staining the surface markers with specific monoclonal antibodies. Figure 1 demonstrates that the percentage of cells positively stained with anti-B220 (B cells) in sham-operated animals was ϳ35-40% of the total LPMC from both mouse strains. The percentage of B cells recovered from the small intestinal LP was significantly decreased in septic C3H/HeJ mice at 24 h. However, these changes were not observed in C3H/ HeJ-FasL gld mice.
Polymicrobial sepsis increases Fas antigen expression in LP B cells from C3H/HeJ but not C3H/HeJFasL
gld mice. To determine whether the Fas/FasL pathway is involved in LP B cell apoptosis during sepsis, two-color staining was performed in isolated LPMC with monoclonal antibodies against B220 (Cychrome labeled) and Fas (FITC labeled). Figure 2 illustrates that there is a marked increase in Fas expression in septic C3H/HeJ mice at 24 h. However, there is no change in Fas antigen expression seen in FasLdeficient mice.
Polymicrobial sepsis increases apoptotic frequency in LP B cells from C3H/HeJ but not C3H/HeJ-FasL gld mice as determined by TUNEL staining. It should be noted that the overall baseline percentage of apoptosis was high, including that for cells from the sham-operated animals (ϳ36%). The reason for this may be due in part to the nature of the purification procedure applied here, which is relatively time consuming and involves treatment with collagenase to dissociate the connective tissue. However, that having been said, the yield and apoptotic rate of the LP B cells obtained here were consistent with the literature (14) and our previous experience using this method of isolation in C3H/HeN mice (11) . Nonetheless, when comparing the effects of FasL deficiency on LP B cell apoptosis, we observed that although a significant increase in the frequency of apoptosis in cells expressing B220 was seen in C3H/ HeJ mice 24 h after CLP, there was no significant change in the B cell population apoptosis between sham-operated and CLP C3H/HeJ-FasL gld mice (Fig.  3) . Although the percentage of apoptosis in LP B cells from FasL gld CLP mice was lower than that in HeJ CLP mice, it did not reach statistical significance.
Light microscopy. To confirm that the changes seen in the ex vivo isolated cells represented in vivo changes in the tissue, paraffin-embedded tissue sections of ileum were stained with hematoxylin and eosin and evaluated by light microscopy. Figure 4 , A and C, which exhibits typical ileal morphology, represents (Fig. 4B) . These changes are characteristic of apoptosis. However, these types of morphological changes were significantly less evident in ileum taken from septic C3H/HeJ-FasL gld mice (Fig.  4D) show feature characteristics of apoptosis, i.e., nuclear condensation, pyknosis, and shrinking cytoplasm. These morphological changes were not observed in the ileum taken from either sham-operated animals (A and C) or FasL-deficient CLP mice (D).
DISCUSSION
Our (11) previous study using C3H/HeN, which is an endotoxin-sensitive mouse strain, indicated that sepsis induces an increased apoptosis in both T and B lymphocytes from small intestinal LP. In this regard, little information is available concerning the nature of the mediator(s) responsible for the induction of this increase in apoptosis seen in mucosal B cells during sepsis. Endotoxin or LPS, a component of Gram-negative bacterial cell wall, is a potent B lymphocyte mitogen and macrophage/monocyte activator that acts to induce apoptosis in T and B cells in vivo and in vitro (10, 36, 38) . Moreover, endotoxin is an important inducer of the septic response. Therefore, endotoxin appeared to be a good candidate mediator that might be responsible for LP B cell death during polymicrobial sepsis. It has also been indicated that Fas/FasL interactions are directly involved in induction of apoptosis in T and B lymphocytes. Recently, studies from our laboratory (4) indicated that intestinal Peyer's patch B cell apoptosis is markedly increased during sepsis, and this appears to involve Fas/FasL. Moreover, Boirivant et al. (7) reported that the increased apoptosis in in vitro stimulated LP T cells is mediated by the Fas/FasL pathway. These findings suggest that Fas/FasL evidently is another candidate for the study of sepsisinduced B cell apoptosis. Thus genetic mutations in Fas (lpr) or FasL (gld) with endotoxin-tolerant background (C3H/HeJ) may provide a powerful tool for analyzing the possible role of these mediators in mucosal B cell apoptosis during sepsis.
Fas (also known as CD95 or Apo-1) is a member of the TNF/nerve growth factor receptor superfamily, which regulates immune cell differentiation, proliferation, activation, and survival on ligation with FasL (belonging to TNF superfamily) or anti-Fas antibody (25) . Fas expression is induced on activated lymphocytes and in nonhemopoietic tissue such as liver, heart, lung, and kidney (32) . Fas expression on B cells has been demonstrated in many laboratories (8, 31) to be critical for activation-induced cell death and elimination of autoreactive B cells. Daniel and Krammer (13) reported that Fas expression is upregulated in B cells that undergo activation-induced apoptosis. In this regard, determination of Fas expression may be useful to provide insight into the role of the Fas/FasL pathway in LP B cell apoptosis during sepsis. Our results using endotoxin-tolerant (C3H/HeJ) and FasL-deficient mice (C3H/HeJ-FasL gld ) showed that LP B cells exhibited increased apoptosis in line with enhanced Fas expression only in septic endotoxin-tolerant mice, which are not deficient in FasL. However, Fas expression in both sham-operated and CLP FasL-deficient mice was higher than in endotoxin-tolerant sham-operated mice. This is in agreement with the finding by Weintraub et al. (33) that Fas expression is increased on B cells in the B6/gld mouse spleen compared with normal B6 control mice. This is also in keeping with the finding that these B cells from B6/gld mice were more susceptible to apoptosis mediated by added soluble anti-Fas antibody (33) . However, the mechanism of the upregulated Fas expression in the LP B cells during sepsis remains unknown.
That said, it is also clear that a number of different apoptotic mediators appear to be contributing to the induction of lymphoid apoptosis during sepsis (4, 20) . In this respect, the apoptotic response to Fas does not appear to be a universal feature in all lymphoid tissues examined in septic mice. Recent studies (6, 23) have shown that p53, a stress-induced anti-tumor transcription factor, may also activate Fas expression. However, Hotchkiss and colleagues (20) reported that sepsisinduced thymocyte, but not splenocyte, apoptosis is a p53-mediated but Fas-independent pathway [using p53 knockout and Fas receptor-deficient (Fas lpr ) mice]. This lack of a Fas-mediated effect has also been documented in previous studies from our laboratory (1), in which it was shown that increased thymocyte apoptosis was not reduced in FasL-deficient (FasL gld ) mice in sepsis. In addition, recent studies (4) have also shown that Peyer's patch B cell, but not T cell, apoptosis is Fas mediated after septic challenge. Thus, although the current results indicate that LP B cell apoptosis appears to be mediated by Fas, we do not suggest that this is a mechanism that can account for all lymphoid apoptosis encountered in septic mice. Moreover, studies (15, 22, 27) have also indicated that stimulation of B cells with addition of endotoxin, CD40 ligand, or interleukin-4 (IL-4) has been demonstrated to upregulate Fas expression. However, endotoxin appears not to be a key player in this process according to our data above. With respect to CD40 ligand, the interaction of CD40 ligand and its receptor CD40 is thought to result in activation and induction of Fas expression in B cells, which then are highly susceptible to Fas-mediated killing by T cells (27) . However, CD40 ligand staining with antibody did not show changes in LP lymphocytes in our hands (data not shown). Recent studies from our laboratory (11) show that sepsis can induce increased apoptosis in LPMC, including T and B cells, that is associated with upregulating cytokine (IL-2, IL-10, and IL-15) mRNA expression. These cytokines might also play a role in the induction of Fas expression in LP B cells. However, inhibition of these cytokines or the genetic deficiency of these agents and the effect on LP B cell apoptosis have not been assessed. Finally, although we have shown here that LP B cell apoptosis is mediated by Fas but not endotoxin, this does not rule out the possible effects of the intact microorganism and/or a combination of other enterotoxins and/or exotoxins that might be released on the induction of Fasmediated apoptosis seen here. However, further study is needed to better delineate the nature of the pathogens or toxins present, besides endotoxin, before such experiments can be conducted.
Two methods, TUNEL staining and light microscopy of hematoxylin and eosin-stained ileal sections, were used to detect apoptosis in our study. TUNEL staining is highly sensitive but low in specificity; however, conventional light microscopy is low in sensitivity but highly specific when characteristic apoptotic morphology is present (18, 34) . Overall, there was a high level of baseline apoptosis in isolated LP B cells from all mice as detected by TUNEL. However, sepsis did induce a marked increase in apoptosis in these cells from C3H/HeJ but not from FasL-deficient mice. Although the percentage of apoptosis in cells from FasL-deficient CLP mice is lower than that from C3H/HeJ CLP mice, they are not statistically significant. These results are consistent with light microscopy examination of samples in which an increase in apoptosis is observed in the ileum of C3H/HeJ but not FasL-deficient septic mice. Furthermore, these morphological differences in the extent of apoptosis between FasL-deficient CLP and C3H/HeJ CLP mice are statistically significant.
With respect to IgA secretory response in septic C3H/HeJ mice, the increase in apoptosis appears to be associated with enhanced endogenous IgA secretion, which is in accord with our previous studies of Peyer's patch B cells (4) . We further identify that this observation was also endotoxin independent and FasL mediated. Fas-mediated induction of apoptosis significantly contributes to elimination of clonal proliferation and regulation of lymphocyte number and turnover in various lymphoid tissues, particularly those continuously exposed to antigen challenge (30) such as the mucosal lymphocytes. Therefore, the increase of apoptosis in intestinal LP B cells along with augmented IgA secretion seen after sepsis would appear to be the result of activation-induced apoptosis. Initially, it may have been speculated that this increase in apoptosis in the activated lymphocytes may be a mechanism to maintain homeostasis that may protect the host from an excessive immune response. However, during overwhelming inflammation, as is thought to be encountered after CLP, aggravated activation-induced apoptosis of lymphocytes may result in humoral immune cell dysfunction. Interestingly, Teodorczyk-Injeyan et al. (28) indicated that nonspecific polyclonal Ig synthesis initially increases and then declines over time after burn injury. The eventual failure of the late Ig release corresponded to higher risk for fatal infectious complications (28) . However, this aberration in IgA release in critical illness appears to be due to impairment of antibody synthesis to specific antigens (35) as opposed nonspecific IgA release.
The present findings show that polymicrobial sepsis induces increased LP B cell apoptosis, which is mediated by Fas/FasL pathway. In addition to identifying the mediator(s) responsible for increased apoptosis, we also performed a survival study using endotoxin-tolerant (C3H/HeJ) and endotoxin-tolerant/FasL-deficient mice (C3H/HeJ-FasL gld ) in an attempt to assess the role of Fas/FasL in morbidity and/or mortality associated with sepsis. It should be noted that the survival rate was not different between endotoxin-sensitive (C3H/HeN) and -tolerant mice (C3H/HeJ) subjected to CLP operation in our previous study (2) . Thus it appears that the significantly lower rate of late mortality observed in FasL-deficient mice after the onset of polymicrobial sepsis is due to FasL and is not a result of the concomitant inability to respond to endotoxin. Although it is tempting to speculate that the protective effects on survival seen here might be related to the decreased apoptosis in the gut LP lymphocytes, we recognize that these protective effects of FasL deficiency may be directed at other immune tissues (phagocytes) and/or at nonimmune cells that also express or perceive FasL. Nonetheless, the significance of these findings and the relative importance of these potentially pathological apoptotic changes, seen here in septic animal lymphoid tissue, have been recently confirmed by Hotchkiss et al. (19) . In that study, Hotchkiss et al. illustrated not only that mice overexpressing the human Bcl-2 gene product (which antagonizes the apoptotic response) showed decreased lymphoid apoptosis after CLP but also that their survival was markedly improved (19) . The degree that this survival advantage was related to the onset of lymphoid apoptosis was based on the finding (19) that RAG-2 mice, deficient in both mature T and B cells, survive septic challenge quite poorly compared with the background controls.
In summary, the increased apoptosis in intestinal LP B lymphocytes after the onset of sepsis appears to be mediated through Fas/FasL pathway. Furthermore, FasL deficiency is also involved in reduction of morbidity and/or mortality seen with septic insult. In light of this, we feel that further studies examining the role of FasL are warranted to clarify the site(s) of action of this agent and potential application of FasL antago-nists as a posttreatment (therapeutic) agent during sepsis.
